How the transmission of Alzheimer's might be possible
New research links dementia cases to injections of human growth hormone from deceased donors' brains
![Photo composite of a human brain, prion proteins, a DNA helix and a doctor with a syringe](https://cdn.mos.cms.futurecdn.net/LKveRAzCJoB3YZQdAP4i6W-415-80.jpg)
Scientists believe that a rare medical treatment withdrawn in the 1980s may have caused some very rare cases of Alzheimer's.
Research published in the Nature Medicine journal suggests the individuals acquired a "rogue protein" that causes dementia from a growth hormone taken from the brains of deceased people, said Sky News.
Although the findings do not mean that Alzheimer's is infectious, the results could have significant implications for our understanding of dementia.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What did the study discover?
Researchers studied eight people in the UK who, as children, received cadaver-derived human growth hormone (c-hGH) that had been extracted from the brains of human corpses.
At least 1,848 people received the c-hGH between the 1950s and 1980s. Some died from Creutzfeldt-Jakob disease (CJD), a degenerative brain condition, because the hormone infusions they received contained infectious proteins called prions that cause severe abnormalities in the brain. Prions are proteins that act like "seeds" of disease, explained Live Science, causing healthy proteins to "fold in abnormal, harmful ways".
The new findings indicate parallels between the evolution of Alzheimer’s and CJD. None of the eight patients in the new study had developed CJD, but five showed symptoms consistent with early-onset Alzheimer's. In three of the patients, biological and autopsy studies supported an Alzheimer's diagnosis, and they were suggestive in a fourth.
Is Alzheimer's transmissible?
Alzheimer's disease is "the most common cause of dementia in the UK", said the NHS. An estimated one in 14 people over the age of 65 has Alzheimer's and other types of dementia, rising to one in six over the age of 80.
Alzheimer's is thought to be caused by the abnormal build-up of proteins in and around brain cells.
"We are not suggesting for a moment that you can catch Alzheimer's disease," said Professor John Collinge, of University College London’s Institute of Prion Diseases, as it is "not transmissible in the sense of a viral or bacterial infection".
Instead, said Live Science, the seed transfer linked to the Alzheimer's cases reported in the new study occurred in a "very specific and extraordinary medical context". And while "in theory", accidental transmissions of Alzheimer's seeds "could be possible in other medical procedures", steps are being taken to avoid any future repeats.
Dr Richard Oakley, associate director of research and innovation at Alzheimer's Society, told Science Media Centre that there was "no cause for concern for the health of the general population", and reiterated that the hormone treatment had not been used since 1985.
Are the results definitive?
No, said Science News. Researchers "can't be certain" that contaminated growth hormone caused these people's Alzheimer's. It is possible that "the underlying childhood conditions that necessitated the growth hormone treatments", or "other medical procedures such as radiation", contributed to early Alzheimer's or cognitive problems.
What are the implications?
As well as preventing similar transmissions, experts hope the findings might increase the understanding of dementia.
"One question is what can be done to stop such transmissions in future," said The Economist, and another is what the findings "might mean for treating Alzheimer's, even in people in whom the disease develops spontaneously".
The findings are a potential boost for research into diagnostics and therapies to combat all forms of dementia, as they might open up new treatment possibilities for a disease that is currently incurable.
The study has "revealed more about how amyloid fragments can spread within the brain", Dr Maëva May, associate director of research at the Stroke Association, told Science Media Centre. This provides "further clues on how Alzheimer's disease progresses and potential new targets for the treatments of tomorrow".
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
Red Speedo: a 'darkly comic' doping drama
The Week Recommends Lucas Hnath's play stars Finn Cole as a 'reptilian' swimmer determined to win at all costs
By Irenie Forshaw, The Week UK Published
-
One Aldwych: where London's creative spirit takes centre stage
The Week Recommends This five-star Covent Garden hotel is the epitome of elegant independence
By Julia O'Driscoll, The Week UK Published
-
Charlotte Dujardin and equestrianism's dark side
In the Spotlight Olympic gold medallist and dressage star's suspension over horse whipping brings abuse in horse sports back into the spotlight
By Harriet Marsden, The Week UK Published
-
Mushroom edibles are tripping up users
the explainer The psychedelics can sometimes have questionable components
By Devika Rao, The Week US Published
-
Have we defeated malaria?
The Explainer Roll-out of low-cost vaccine means a world free from disease that claims 600,000 lives a year 'finally within sight'
By The Week UK Published
-
Neurocosmetics: the beauty trend blending mental health and skin care
The Explainer Could a moisturizer really shift your mood?
By Theara Coleman, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
What is sickle cell anaemia?
The Explainer The UK has approved the use of a new drug to treat a disease that predominantly affects people of colour
By Keumars Afifi-Sabet, The Week UK Published
-
A study found toxic heavy metals in most tampon brands. Are they safe to use?
The Explainer Over a dozen brands tested positive, including organic tampons
By Theara Coleman, The Week US Published
-
The great baby bust
The Explainer The fertility rate is falling sharply in the UK and across the world, a trend with major economic and societal consequences
By The Week UK Published
-
The US is at risk for dengue fever
The explainer The buzz surrounding the mosquito-borne illness
By Devika Rao, The Week US Published